SER-155-001, NCT04995653: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT |
|
|
| Completed | 1 | 60 | US | Vancomycin Pre-Treatment, Vancomycin Placebo, SER-155, SER-155 Placebo | Seres Therapeutics, Inc., Memorial Sloan Kettering Cancer Center | Allogeneic Hematopoietic Stem Cell Transplantation | 07/24 | 07/24 | | |